Mefenamic Acid

Mefenamic Acid works by inhibiting cyclooxygenase (COX) enzymes, which are essential for the formation of prostaglandins. By reducing prostaglandin synthesis, the drug lowers inflammation, pain, and fever associated with various conditions.

The appropriate dose of Mefenamic Acid is determined by a qualified prescriber based on the individual’s medical condition, age, and response to therapy. Patients should follow the specific instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of Mefenamic Acid in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their doctor.

To order Mefenamic Acid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and any necessary import documentation.

Mefenamic Acid is similar to other NSAIDs in its mechanism of COX inhibition but is often chosen for its efficacy in treating dysmenorrhea and certain inflammatory pains. Compared with ibuprofen or naproxen, it may have a slightly higher risk of gastrointestinal side effects, so clinicians weigh benefits against individual patient risk profiles.

Mefenamic Acid tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Mefenamic Acid is administered orally, typically as a tablet taken with a full glass of water. It may be taken with or without food, but taking it with food can help reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal bleeding or ulceration, severe kidney impairment, liver dysfunction, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice blood in stool or urine, persistent abdominal pain, yellowing of the skin or eyes, or a widespread rash.

Mefenamic Acid should be avoided by individuals with a known hypersensitivity to the drug or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, or significant renal or hepatic impairment. It is also contraindicated in patients taking anticoagulants together with SSRIs or other drugs that increase bleeding risk.